Martin Fan
Stock Analyst at Wedbush
(1.60)
# 3,162
Out of 4,874 analysts
5
Total ratings
80%
Success rate
-3.74%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Martin Fan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACRS Aclaris Therapeutics | Initiates: Outperform | $8 | $1.56 | +412.82% | 1 | May 28, 2025 | |
| ORKA Oruka Therapeutics | Reiterates: Outperform | $40 | $11.63 | +243.94% | 1 | May 15, 2025 | |
| ANAB AnaptysBio | Reiterates: Outperform | $40 | $23.38 | +71.09% | 1 | May 1, 2025 | |
| ARTV Artiva Biotherapeutics | Reiterates: Outperform | $18 | $1.57 | +1,046.50% | 1 | Mar 25, 2025 | |
| ZBIO Zenas BioPharma | Initiates: Outperform | $35 | $10.15 | +244.83% | 1 | Mar 20, 2025 |
Aclaris Therapeutics
May 28, 2025
Initiates: Outperform
Price Target: $8
Current: $1.56
Upside: +412.82%
Oruka Therapeutics
May 15, 2025
Reiterates: Outperform
Price Target: $40
Current: $11.63
Upside: +243.94%
AnaptysBio
May 1, 2025
Reiterates: Outperform
Price Target: $40
Current: $23.38
Upside: +71.09%
Artiva Biotherapeutics
Mar 25, 2025
Reiterates: Outperform
Price Target: $18
Current: $1.57
Upside: +1,046.50%
Zenas BioPharma
Mar 20, 2025
Initiates: Outperform
Price Target: $35
Current: $10.15
Upside: +244.83%